2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Papillomavirus Infections
24
Uterine Cervical Neoplasms
20
Uterine Cervical Dysplasia
9
Condylomata Acuminata
7
Anus Neoplasms
5
Vulvar Neoplasms
4
Vaginal Neoplasms
3
HIV Infections
2
Whooping Cough
1
Virus Diseases
1
Tetanus
1
Persistent Infection
1
Neoplasms, Glandular and Epithelial
1
Neoplasms
1
Neoplasm Metastasis
1
Meningitis
1
Lung Neoplasms
1
Keratosis, Actinic
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Genital Human Papilloma Virus Infection
1
Endometrial Neoplasms
1
Diphtheria
1
Crohn Disease
1
Colitis, Ulcerative
1
Cervical Cancer Screening
1
Carcinoma, Squamous Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Acquired Immunodeficiency Syndrome
1
Interventions
pembrolizumab
157
Gemcitabine
140
Capecitabine
123
Paclitaxel
121
Fluorouracil
117
Oxaliplatin
110
Bevacizumab
106
Nivolumab
99
Docetaxel
98
Leucovorin
97
Cisplatin
90
Radiosurgery
88
Irinotecan
88
Carboplatin
86
Cyclophosphamide
72
Cetuximab
72
Magnetic Resonance Spectroscopy
68
Specimen Handling
60
Radiotherapy
60
Trastuzumab
59
Biopsy
59
Ipilimumab
53
Drug Therapy
51
Everolimus
48
Pemetrexed
46
Albumin-Bound Paclitaxel
45
130-nm albumin-bound paclitaxel
44
Doxorubicin
42
Fulvestrant
40
aldesleukin
37
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
Papillomavirus Vaccines
×
Clear all
NCT06686043
2024-11-13
HPV-VIM
Baylor College of Medicine
Phase 2
Recruiting
85 enrolled